SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for In-Process Checks during Packaging Operations – V 2.0

Sterile Injectable Manufacturing: SOP for In-Process Checks during Packaging Operations – V 2.0

Standard Operating Procedure for In-Process Checks during Packaging Operations


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/100/2025
Supersedes SOP/SIM/100/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standardized procedure for conducting in-process checks during the packaging of sterile injectable products to ensure compliance with GMP and product specifications.

2. Scope

This SOP is applicable to all packaging lines used for sterile injectable vials, ampoules, and prefilled syringes in

the sterile manufacturing facility.

3. Responsibilities

  • Packaging Operator: Perform assigned checks and document results.
  • IPQA Officer: Independently verify in-process checks, document deviations, and initiate CAPA if required.
  • Packaging Supervisor: Ensure compliance with in-process checking protocol.

4. Accountability

The Head – Quality Assurance shall be accountable for implementation, compliance, and revision of this SOP.

5. Procedure

5.1 Types of In-Process Checks

  1. Visual inspection of vials, ampoules, or prefilled syringes for:
    • Cracks, particles, color changes
    • Incorrect labeling or orientation
  2. Label verification and legibility
  3. Overprinting verification (Batch No., Mfg Date, Exp Date)
  4. Sealing integrity of vials or syringes
  5. Carton count and packaging insert verification
  6. Shipper and pallet labeling checks

5.2 Frequency of Checks

  1. Conduct in-process checks at the beginning of the batch and then at every 30-minute interval or as per SOP/SIM/XXX/2025.
  2. Immediately record the results in Annexure-1.

5.3 Acceptable Criteria

  1. All printed information must be legible and correct.
  2. No leaks, broken containers, or improper seals.
  3. Carton contents must match batch packaging record.

5.4 Handling of Deviations

  1. Stop the packaging activity if any deviation is observed.
  2. Inform the QA officer and initiate deviation report (Annexure-2).
  3. Only resume after CAPA approval from QA.

5.5 Reconciliation

  1. Ensure proper reconciliation of:
    • Primary packaging components
    • Printed secondary materials
  2. Document the reconciliation in Annexure-3.

5.6 Review and Documentation

  1. QA must review and sign off all in-process check records.
  2. Ensure completeness and correctness before batch release.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • CAPA: Corrective and Preventive Action

7. Documents

  1. In-Process Packaging Check Sheet – Annexure-1
  2. Deviation Report – Annexure-2
  3. Reconciliation Record – Annexure-3

8. References

  • WHO TRS 986 Annex 6: GMP for Sterile Products
  • 21 CFR Part 211 – Finished Pharmaceuticals
  • EudraLex Volume 4 – Annex 1

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: In-Process Packaging Check Sheet

Date Time Parameter Checked Result Checked By
18/06/2025 10:00 Label Alignment OK Sunita Rao

Annexure-2: Deviation Report

Date Deviation Observed Immediate Action CAPA Proposed QA Reviewed
18/06/2025 Faded overprint Stopped Line Printer calibration Ramesh Iyer

Annexure-3: Reconciliation Record

Material Issued Used Returned Destroyed Checked By
Labels 10000 9800 150 50 Sneha Kulkarni

Revision History

Revision Date Revision No. Details Reason Approved By
15/03/2022 1.0 Initial SOP Release New SOP Head QA
18/06/2025 2.0 Added reconciliation and frequency update Annual Review Head QA
Exit mobile version